UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5-fluorouracil-related side effects

Human mutation, 2003-12, Vol.22 (6), p.498-498

2003

Volltextzugriff (PDF)

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model

Oncogene, 2003-07, Vol.22 (30), p.4642-4647

2003

Volltextzugriff (PDF)

Blood component use and associated costs after standard dose chemotherapy—a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

Supportive care in cancer, 2012-05, Vol.20 (5), p.1011-1021

2012

Volltextzugriff (PDF)

Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: Analysis of remission induction and stem cell mobilization

Leukemia & lymphoma, 2008-01, Vol.49 (7), p.1337-1344

2008

Volltextzugriff (PDF)

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

Blood, 2001-09, Vol.98 (5), p.1326-1331

2001

Volltextzugriff (PDF)

Psychoedukative Patientengruppen im Rahmen einer interdisziplinären Tumortherapie/ Interdisciplinary psychoeducational intervention by oncologists proved helpful for cancer patients

Zeitschrift für Psychosomatische Medizin und Psychotherapie, 2003-09, Vol.49 (3), p.246-261

2003

Volltextzugriff (PDF)

Response to Chemotherapy, Reexposure to Crizotinib and Treatment with a Novel ALK Inhibitor in a Patient with Acquired Crizotinib Resistance

Respiration, 2014-01, Vol.88 (3), p.262-264

2014

Volltextzugriff (PDF)

Strukturierte Patientenschulung in der Onkologie: Eine prospektive Studie zur Implementierung und Wirksamkeit einer interdisziplinären psychoedukativen Gruppenintervention an einer deutschen Universitätsklinik

Medizinische Klinik (München. 1983), 2002-08, Vol.97 (8), p.449-454

2002

Volltextzugriff (PDF)

Biodistribution and kinetics of 131I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma

European journal of nuclear medicine and molecular imaging, 2002-10, Vol.29 (10), p.1276-1282

2002

Volltextzugriff (PDF)

A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study

Leukemia & lymphoma, 2009-01, Vol.50 (5), p.716-722

2009

Volltextzugriff (PDF)

Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone

The American journal of surgical pathology, 2010-09, Vol.34 (9), p.1382-1387

2010

Volltextzugriff (PDF)

Phase I/II Study of Myeloablative Anti-CD20+ Radioimmunotherapy with I-131-Rituximab in High-Risk CD20-Positive Non Hodgkin Lymphoma

Blood, 2012-11, Vol.120 (21), p.3700-3700

2012

Volltextzugriff (PDF)

The Severe Combined Immunodeficient-Human Peripheral Blood Stem Cell (SCID-huPBSC) Mouse: A Xenotransplant Model for huPBSC-Initiated Hematopoiesis

Blood, 1995-07, Vol.86 (1), p.89-100

1995

Volltextzugriff (PDF)

Acupuncture and acupressure for the prevention of chemotherapy-induced nausea--a randomised cross-over pilot study

Supportive care in cancer, 2006-08, Vol.14 (8), p.878-882

2006

Volltextzugriff (PDF)

Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival

Oncotarget, 2013-06, Vol.4 (6), p.899-910

2013

Volltextzugriff (PDF)

Peripheral Blood Stem-Cell Mobilisation and Autologous Stem Cell Transplantation In HIV-Related Malignancies

Blood, 2010-11, Vol.116 (21), p.4592-4592

2010

Volltextzugriff (PDF)

Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

Supportive care in cancer, 2012-05, Vol.20 (5), p.1011

2012

Volltextzugriff (PDF)

Immunotherapy with anti-CD20 compounds

Seminars in cancer biology, 2003-06, Vol.13 (3), p.211-222

von Schilling, Christoph

2003

Volltextzugriff (PDF)

Immunohistochemistry in bone marrow pathology : a useful adjunct for morphologic diagnosis

Virchows Archiv : an international journal of pathology, 2005-12, Vol.447 (6), p.920-937

2005

Volltextzugriff (PDF)

Immunotherapy with anti-CD20 compounds: MRD in follicular lymphoma - cellular evolution, detection & treatment

Seminars in cancer biology, 2003, Vol.13 (3), p.211-222

VON SCHILLING, Christoph

2003

Volltextzugriff (PDF)

Against

European journal of nuclear medicine and molecular imaging, 2002-09, Vol.29 (9), p.1254-1256

von Schilling, Christoph

2002

Volltextzugriff (PDF)

Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer

Onkologie, 2011-01, Vol.34 (5), p.241-246

2011

Volltextzugriff (PDF)

The Economic Burden of Chemotherapy-Induced Toxicity in Lymphoma and NSCLC Routine Hospital Care

Blood, 2008-11, Vol.112 (11), p.4701-4701

2008

Volltextzugriff (PDF)

Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network

Blood, 2007-11, Vol.110 (11), p.4501-4501

2007

Volltextzugriff (PDF)

Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against

European journal of nuclear medicine and molecular imaging, 2002-09, Vol.29 (9), p.1254

von Schilling, Christoph

2002

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(182)

Publikationsform

Buchkapitel
(97)
Artikel
(86)
Bücher
(16)

Sprache

Deutsch
(142)
Englisch
(58)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Female
(14)
Male
(14)
Middle Aged
(12)
Aged
(11)
Ancient History: To C 500 Ce
(11)
Early Modern History: C 1450/1500 To C 1700
(11)
Medieval History
(11)
Adult
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Animals
(7)
Oncology
(7)
Mice
(6)
Antibodies, Monoclonal, Murine-Derived
(5)
Chemotherapy
(5)
Immunohistochemistry
(5)
Rituximab
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5-fluorouracil-related side effects

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model

Blood component use and associated costs after standard dose chemotherapy—a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: Analysis of remission induction and stem cell mobilization

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

Psychoedukative Patientengruppen im Rahmen einer interdisziplinären Tumortherapie/ Interdisciplinary psychoeducational intervention by oncologists proved helpful for cancer patients

Response to Chemotherapy, Reexposure to Crizotinib and Treatment with a Novel ALK Inhibitor in a Patient with Acquired Crizotinib Resistance

Strukturierte Patientenschulung in der Onkologie: Eine prospektive Studie zur Implementierung und Wirksamkeit einer interdisziplinären psychoedukativen Gruppenintervention an einer deutschen Universitätsklinik

Biodistribution and kinetics of 131I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma

A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study

Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone

Phase I/II Study of Myeloablative Anti-CD20+ Radioimmunotherapy with I-131-Rituximab in High-Risk CD20-Positive Non Hodgkin Lymphoma

The Severe Combined Immunodeficient-Human Peripheral Blood Stem Cell (SCID-huPBSC) Mouse: A Xenotransplant Model for huPBSC-Initiated Hematopoiesis

Acupuncture and acupressure for the prevention of chemotherapy-induced nausea--a randomised cross-over pilot study

Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival

Peripheral Blood Stem-Cell Mobilisation and Autologous Stem Cell Transplantation In HIV-Related Malignancies

Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

Immunotherapy with anti-CD20 compounds

Immunohistochemistry in bone marrow pathology : a useful adjunct for morphologic diagnosis

Immunotherapy with anti-CD20 compounds: MRD in follicular lymphoma - cellular evolution, detection & treatment

Against

Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer

The Economic Burden of Chemotherapy-Induced Toxicity in Lymphoma and NSCLC Routine Hospital Care

Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network

Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against

Suchergebnisse filtern